Inventor · disambiguated record
Liangqin Guo
Also filed as: GUO LIANGQIN
30 granted patents·6 pending applications·169 citations·filing 1998–2022
94Inventor score
Files withMERCK SHARP & DOHME14MERCK & CO INC8MERCK SHARP & DOHME LLC8GUO LIANGQIN2BARAKAT KHALED J1
Top patents by PatentIndex Score
36 records- 0195US11484565B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2020·Granted Nov 1, 2022·3 cites·18 claims
- 0290US6458790B2Substituted piperidines as melanocortin receptor agonistsMERCK & CO INC·Filed 2001·Granted Oct 1, 2002·56 cites·29 claims
- 0382US12091405B2Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 17, 2024·2 cites·13 claims
- 0481US12152019B2Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 26, 2024·2 cites·20 claims
- 0577US6025372ASomatostatin agonistsMERCK & CO INC·Filed 1998·Granted Feb 15, 2000·45 cites·19 claims
- 0675US7276520B2Bicyclic piperidine derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2004·Granted Oct 2, 2007·8 cites·21 claims
- 0774US6063796ASomatostatin agonistsMERCK & CO INC·Filed 1998·Granted May 16, 2000·38 cites·13 claims
- 0872US10519147B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Dec 31, 2019·1 cites·18 claims
- 0972US10221167B2Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·1 cites·46 claims
- 1071US12178842B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2022·Granted Dec 31, 2024·0 cites·18 claims
- 1171US6387932B1Somatostatin agonistsMERCK & CO INC·Filed 2000·Granted May 14, 2002·7 cites·12 claims
- 1270US7652024B2Acylated spiropiperidine derivatives as melanocortin-4 receptor modulatorsMERCK SHARP & DOHME·Filed 2006·Granted Jan 26, 2010·2 cites·19 claims
- 1364US7329673B2Acylated spiropiperidine derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2004·Granted Feb 12, 2008·2 cites·22 claims
- 1461US8754099B2Oxadiazole beta carboline derivatives as antidiabetic compoundsGUO LIANGQIN·Filed 2011·Granted Jun 17, 2014·1 cites·17 claims
- 1560US7160886B2Acylated piperazine derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2004·Granted Jan 9, 2007·1 cites·31 claims
- 1655US2024018145A1Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenzaMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 1753US12246008B24-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 1852US11352320B2Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jun 7, 2022·0 cites·14 claims
- 1951US12065438B2Substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Aug 20, 2024·0 cites·19 claims
- 2051US11478461B2[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Oct 25, 2022·0 cites·19 claims
- 2151US2019233406A1HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELSMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2248US12264134B2Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·0 cites·21 claims
- 2347US9914727B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 13, 2018·0 cites·6 claims
- 2447US2011201615A1Triazole beta carboline derivatives as anti-diabetic agentsGUO LIANGQIN·Filed 2009·Application pending·0 cites
- 2546US10968210B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2017·Granted Apr 6, 2021·0 cites·19 claims
- 2646US9708308B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·0 cites·16 claims
- 2744US11034661B2Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Jun 15, 2021·0 cites·19 claims
- 2844US10927086B2Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Feb 23, 2021·0 cites·20 claims
- 2942US10988487B2Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Apr 27, 2021·0 cites·20 claims
- 3042US2010234409A1Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activityYANG LIHU·Filed 2005·Application pending·0 cites
- 3141US7115628B2Bridged piperidine derivatives as melanocortin receptor agonistsMERCK & CO INC·Filed 2002·Granted Oct 3, 2006·0 cites·19 claims
- 3241US2008051430A1Acylated Piperidine Derivatives as Melanocortin 4-Receptor AgonistsBARAKAT KHALED J·Filed 2005·Application pending·0 cites
- 3341US2010184758A1Beta carboline derivatives as antidiabetic compoundsDOBBELAAR PETER H·Filed 2008·Application pending·0 cites
- 3440US10189819B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 29, 2019·0 cites·14 claims
- 3540US9695198B2Factor IXa inhibitorsSMITH CAMERON JAMES·Filed 2013·Granted Jul 4, 2017·0 cites·5 claims
- 3639US10538497B2Compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jan 21, 2020·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Liangqin Guo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →